https://orcid.org/0000-0003-3474-5070
References
- Rund D, Rachmilewitz E. β-thalassemia. N Engl J Med. 2005;353(11):1135–1146.
- Başak AN. The molecular pathology of β-thalassemia in Turkey: the Boğaziçi University experience. Hemoglobin. 2007;31(2):233–241.
- Canatan D. Thalassemias and hemoglobinopathies in Turkey. Hemoglobin. 2014;38(5):305–307.
- Cao A, Galanello R. β-thalassemia. Genet Med. 2010;12(2):61–76.
- Al-Amodi AM, Ghanem NZ, Aldakeel SA, et al. Hemoglobin A2 (HbA2) has a measure of unreliability in diagnosing β-thalassemia trait (β-TT). Curr Med Res Opin. 2018;34(5):945–951.
- Martin A, Thompson AA. Thalassemias. Pediatr Clin North Am. 2013;60(6):1383–1391.
- Scott MD, Van den Berg JJ, Repka T, et al. Effect of excess alpha-hemoglobin chains on cellular and membrane oxidation in model beta-thalassemic erythrocytes. J Clin Invest. 1993;91(4):1706–1712.
- Guzelcicek A, Cakirca G, Erel O, et al. Assessment of thiol/disulfide balance as an oxidative stress marker in children with β-thalassemia major. Pak J Med Sci. 2019;35(1):161–165.
- Bazvand F, Shams S, Borji Esfahani MB, et al. Total antioxidant status in patients with major β-thalassemia. Iran J Pediatr. 2011;21(2):159–165.
- Kassab-Chekir A, Laradi S, Ferchichi S, et al. Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clin Chim Acta. 2003;338(1-2):79–86.
- Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med. 2010;48(6):749–762.
- Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem. 2014;47(18):326–332.
- Thein SL. The molecular basis of β-thalassemia. Cold Spring Harb Perspect Med. 2013;3(5):a011700.
- Cao A, Kan YW. The prevention of thalassemia. Cold Spring Harb Perspect Med. 2013;3(2):a011775.
- Tyan PI, Radwan AH, Eid A, et al. Novel approach to reactive oxygen species in nontransfusion-dependent thalassemia. Biomed Res Int. 2014;2014:350432.
- Ribeil JA, Arlet JB, Dussiot M, et al. Ineffective erythropoiesis in β -thalassemia. ScientificWorldJournal. 2013;2013:394295.
- De Franceschi L, Bertoldi M, Matte A, et al. Oxidative stress and β-thalassemic erythroid cells behind the molecular defect. Oxid Med Cell Longev. 2013;2013:985210.
- Şimşek F, Öztürk G, Kemahlı S, et al. Oxidant and antioxidant status in β thalassemia major patients. J Ankara Univ Fac Med. 2005;58(1):34–38.
- Abdalla MY, Fawzi M, Al-Maloul SR, et al. Increased oxidative stress and iron overload in Jordanian β-thalassemic children. Hemoglobin. 2011;35(1):67–79.
- Meral A, Tuncel P, Sürmen-Gür E, et al. Lipid peroxidation and antioxidant status in β-thalassemia. Pediatr Hematol Oncol. 2000;17(8):687–693.
- Shekhar H, Hossain MF, Ismail M, et al. Respiratory burst enzymes, pro-oxidants and antioxidants status in Bangladeshi population with β-thalassemia major. North Am J Med Sci. 2015;7(6):253–258.
- Nagy P. Kinetics and mechanisms of thiol-disulfide exchange covering direct substitution and thiol oxidation-mediated pathways. Antioxid Redox Signal. 2013;18(13):1623–1641.
- Manafikhi H, Drummen G, Palmery M, et al. Total antioxidant capacity in β-thalassemia: a systematic review and meta-analysis of case-control studies. Crit Rev Oncol Hematol. 2017;110:35–42.
- Işik Odaman A, Ayçiçek A, Ersoy G, et al. Thiol disulfide homeostasis and ischemia-modified albumin level in children with β-thalassemia. J Pediatr Hematol Oncol. 2019;41(7):463–466.